Innovative Drug Development to Solve the Greatest Challenges in Cancer Care
Targeted therapies for previously “untargetable” mutations that drive the deadliest cancers
Novel mechanisms to defeat cancer growth and survival, likely to synergize with a wide array of conventional and other targeted therapies/immunotherapies
RasCal Therapeutics is currently conducting human clinical trials of its lead anti-cancer compound
Contact us.
info@rascaltherapeutics.com